CRISPR THERAPEUTICS AG Cash Equivalents, at Carrying Value
CRISPR THERAPEUTICS AG (CRSP) had Cash Equivalents, at Carrying Value of $30.64 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-03
- 2026-06-30: Cash Equivalents, at Carrying Value $30.64M.
- 2026-03-31: Cash Equivalents, at Carrying Value $60.47M.
- 2025-12-31: Cash Equivalents, at Carrying Value $52.15M.
- 2025-09-30: Cash Equivalents, at Carrying Value $84.57M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $30.64M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $60.47M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $52.15M 10-Q · filed 2026-08-03 |
| 2025-09-30 | $84.57M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $93.99M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $97.48M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $104.31M 10-K · filed 2026-02-12 |
| 2024-09-30 | $121.91M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $296.57M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $252.52M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $191.72M 10-K · filed 2025-02-11 |
| 2023-09-30 | $378.54M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $113.36M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $80.83M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $52.59M 10-K · filed 2024-02-21 |
| 2022-09-30 | $214.30M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $113.56M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $545.12M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $517.38M 10-K · filed 2023-02-21 |
| 2021-09-30 | $530.48M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $666.03M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $631.89M 10-Q · filed 2021-04-27 |
| 2020-12-31 | $773.56M 10-K · filed 2022-02-15 |
| 2020-09-30 | $915.70M 10-Q · filed 2020-10-28 |
| 2018-12-31 | $456.60M 10-K · filed 2019-02-25 |
| 2017-12-31 | $239.80M 10-K · filed 2019-02-25 |
| 2016-12-31 | $315.50M 10-K · filed 2018-03-08 |
| 2015-12-31 | $156.00M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |